Kenneth B. Lee Jr.

Director, POZEN INC /NC.

Companies

BioCryst PharmaceuticalsBoard member Jun 28, 2011 to Jun 15, 2023¹
HYPERION DEFI, INC.Board member Apr 5, 2018 to Jun 21, 2022²
MaxygenBoard member Sep 24, 2009 to Jun 7, 2012³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

BioCryst Pharmaceuticals BCRX68,863 shares⁴$549.9K at $7.99Jun 13, 2023
HYPERION DEFI, INC. HYPD64,544 shares⁵$183.5K at $2.84Jun 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals⁴
Jan 31, 2023Exercised options 15,000 shares at $1.71 of BioCryst Pharmaceuticals⁶
Jun 16, 2022Granted 22,222 shares of HYPERION DEFI, INC.⁵
Jun 7, 2022Granted 12,866 shares of BioCryst Pharmaceuticals⁷
May 19, 2022Bought 10,000 shares at $2.20 of HYPERION DEFI, INC.⁸
Nov 17, 2021Granted 6,963 shares of HYPERION DEFI, INC.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioCryst Pharmaceuticals, Board member
2
SEC EDGARHYPERION DEFI, INC., Board member
3
SEC EDGARMaxygen, Board member
4
SEC EDGARBioCryst Pharmaceuticals shares after the filing of Jun 13, 2023
5
SEC EDGARHYPERION DEFI, INC. shares after the filing of Jun 16, 2022
6
SEC EDGARForm 4 filed Feb 2, 2023
7
SEC EDGARForm 4 filed Jun 9, 2022
8
SEC EDGARForm 4 filed May 23, 2022
9
SEC EDGARForm 4 filed Nov 22, 2021